Table 1.B. infantis 35624-feeding induces a reduction in absolute CRP levels in the majority of inflammatory disorder patients compared with placebo-fed patients. Results expressed as median (interquartile ranges).
| Disease Indication | Treatment | Biomarker | Pre-treatment level (mg/L) | Post-treatment level (mg/L) |
|---|---|---|---|---|
|
Chronic Fatigue Syndrome |
B. infantis |
CRP |
2.35 (1.36–5.65) |
2.07(1.05–4.77) |
| Placebo |
CRP |
1.92 (0.41–9.78) |
3.02 (1.52–9.72) |
|
|
Psoriasis |
B. infantis |
CRP |
4.47 (3.59–7.97) |
2.89 (2.02–5.36) |
| Placebo |
CRP |
2.68 (1.33–4.33) |
3.55 (2.46–5.79) |
|
| Ulcerative Colitis |
B. infantis |
CRP |
3.81 (1.67–10.66) |
1.82 (0.83–15.18) |
| Placebo | CRP | 8.91 (1.18–50.94) | 36.20 (3.26–86.14) |